Invention Grant
- Patent Title: Peptide tyrosinase inhibitors and uses thereof
- Patent Title (中): 肽酪氨酸酶抑制剂及其用途
-
Application No.: US14117012Application Date: 2012-05-10
-
Publication No.: US09320698B2Publication Date: 2016-04-26
- Inventor: Basil M. Hantash , Anan Abu Ubeid
- Applicant: Basil M. Hantash , Anan Abu Ubeid
- Applicant Address: US CA San Jose
- Assignee: Escape Therapeutics, Inc.
- Current Assignee: Escape Therapeutics, Inc.
- Current Assignee Address: US CA San Jose
- Agency: Aka Chan LLP
- International Application: PCT/US2012/037332 WO 20120510
- International Announcement: WO2012/154959 WO 20121115
- Main IPC: A61K8/64
- IPC: A61K8/64 ; C07K7/06 ; C12N9/02 ; A61Q19/02 ; A61K8/14 ; C07K5/11 ; A61Q19/00 ; A61K38/00

Abstract:
Disclosed are peptides that inhibit the enzymatic activity of tyrosinase, as well as formulations and methods for their use in the reduction of skin pigmentation, and methods of administering the inhibitory pep tides in a topical formulation. Preferred octapeptide sequences are internally rich in tryptophan and/or tyrosine or arginine. The present invention is further directed to kits and compositions containing the present peptides, and methods of treatment of conditions involving expression of tyrosinase, in which the present peptides are administered topically for the treatment of conditions involving melanocyte activity in the skin.
Public/Granted literature
- US20150118286A1 Peptide Tyrosinase Inhibitors and Uses Thereof Public/Granted day:2015-04-30
Information query